Michigan

Public Acts 246-55 of 2017: Effective 6/1/2018:
- Prescriber must discuss: Dangers of opioid addiction; how to dispose of unwanted controlled substances; that delivery of a controlled substance is a felony; must disclose to pregnant patients dangers to fetus.
- Patients must sign consent for opioid use
- Prescribers have to prove “bona fide prescriber-patient relationship with the patient” (effective date is 3/31/19), defined as “prescriber has reviewed medical record and made a full assessment of the patient’s medical history and current condition” and the prescriber has “created and maintained records of the patient’s condition in accordance with medically accepted standards”.
- Prescribers have to provide follow-up care after prescription is given or refer to PCP or “another licensed provider who is geographically accessible” for follow-up
- Greater than 3-day supply requires consulting MAPS (PMP) and as of 6/1/18 prescribers must register with MAPS
- Acute pain limited to 7-day prescriptions
- Pharmacists can partial fill prescriptions